Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Ignyta
is defunct.
Acquired by Roche, Feb 2018; $1.2B
------------------
If you believe any of this information is incorrect, please
let us know
.